TELO GENOMICS CORP (TELO.CA) Stock Price, Forecast & Analysis
Canada - TSX-V:TELO - CA87975M2085 - Common Stock
TELO.CA Key Statistics, Chart & Performance
The current stock price of TELO.CA is 0.075 CAD. In the past month the price increased by 7.14%. In the past year, price decreased by -42.31%.
TELO.CA Latest News, Press Relases and Analysis
TELO.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 470.58M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 406.00M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 179.49M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 118.44M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 24.88 | 54.57M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | N/A | 34.18M | ||
| RVX.CA | RESVERLOGIX CORP | N/A | 28.67M | ||
| BCT.CA | BRIACELL THERAPEUTICS CORP | N/A | 24.31M | ||
| HEM.CA | HEMOSTEMIX INC | N/A | 16.56M | ||
| MPH.CA | MEDICURE INC | N/A | 13.05M | ||
| CSCI.CA | COSCIENS BIOPHARMA INC | N/A | 10.72M | ||
| QPT.CA | QUEST PHARMATECH INC | N/A | 6.77M |
Related stock screener links
About TELO.CA
Company Profile
Telo Genomics Corp. is a molecular diagnostics company, which engages in the development of telomere analysis platforms in the industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2012-02-15. Its technologies utilize a multi-step process that involves capturing sample cells from blood or tissue, labeling, 3D formatting, processing and analyzing with TeloView. Its technologies are based on single cell biology. TeloView is a software platform, which is used to quantify specific features of each patient’s telomeres. The company quantifies six specific biological and structural features of telomeres and builds a score for each patient to assess their risk of disease progression and potential treatment response. TeloView helps in capturing the heterogeneity and complexity of cancers with relatively small sample sizes in clinical studies. Its initial lead includes multiple myeloma, prostate cancer and Alzheimer's disease.
Company Info
TELO GENOMICS CORP
Mars Centre, 101 College St Suite 200
TORONTO ONTARIO M5G 1L7 CA
CEO: Sherif Louis
Employees: 6
Phone: 14166738487
TELO GENOMICS CORP / TELO.CA FAQ
Can you describe the business of TELO GENOMICS CORP?
Telo Genomics Corp. is a molecular diagnostics company, which engages in the development of telomere analysis platforms in the industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2012-02-15. Its technologies utilize a multi-step process that involves capturing sample cells from blood or tissue, labeling, 3D formatting, processing and analyzing with TeloView. Its technologies are based on single cell biology. TeloView is a software platform, which is used to quantify specific features of each patient’s telomeres. The company quantifies six specific biological and structural features of telomeres and builds a score for each patient to assess their risk of disease progression and potential treatment response. TeloView helps in capturing the heterogeneity and complexity of cancers with relatively small sample sizes in clinical studies. Its initial lead includes multiple myeloma, prostate cancer and Alzheimer's disease.
What is the current price of TELO stock?
The current stock price of TELO.CA is 0.075 CAD. The price increased by 25% in the last trading session.
Does TELO stock pay dividends?
TELO.CA does not pay a dividend.
What is the ChartMill rating of TELO GENOMICS CORP stock?
TELO.CA has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the sector and industry classification for TELO GENOMICS CORP?
TELO GENOMICS CORP (TELO.CA) operates in the Health Care sector and the Biotechnology industry.
Can you provide the PE ratio for TELO stock?
TELO GENOMICS CORP (TELO.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.03).
TELO.CA Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to TELO.CA. When comparing the yearly performance of all stocks, TELO.CA is a bad performer in the overall market: 89.76% of all stocks are doing better.
TELO.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to TELO.CA. TELO.CA has a great financial health rating, but its profitability evaluates not so good.
TELO.CA Financial Highlights
Over the last trailing twelve months TELO.CA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 18.68% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -298.34% | ||
| ROE | -527.92% | ||
| Debt/Equity | 0 |